Filing Details

Accession Number:
0001104659-21-142473
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-22 16:05:53
Reporting Period:
2021-11-19
Accepted Time:
2021-11-22 16:05:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1736243 Acurx Pharmaceuticals Inc. ACXP Pharmaceutical Preparations (2834) DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1127423 J Robert Deluccia C/O Acurx Pharmaceuticals, Inc.,
259 Liberty Avenue
Staten Island NY 10305
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-19 5,034 $4.90 1,031,461 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,847 Indirect By spouse
Footnotes
  1. The price reflects the average purchase price of the shares of common stock purchased. These shares of common stock were purchased in multiple transactions at prices ranging from $4.886 to $4.961 per share of common stock. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares of common stock purchased at each price.